Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1127, pseudogene (RNU6-1127P)
- Target
- RNU6-1127P
- Molecular classification
- Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene
01
Overview
RNU6-1127P is a non-coding, processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene, which is part of the cellular machinery required for excising introns from pre-mRNA as part of the spliceosome complex[1][5]. However, as a pseudogene, RNU6-1127P does not produce a functional RNA product and plays no active role in splicing, cellular signaling, or disease mechanisms[2][4]. It is classified as a non-functional remnant generated by retrotransposition, often through L1-mediated mechanisms that copy the original snRNA sequence into new genomic loci[2][4]. These pseudogenes are common in mammalian genomes but are not considered therapeutic or diagnostic targets.
- Other names
- RNU6-1127PRNA, U6 small nuclear 1127, pseudogeneENSG00000207310106480640
02
Mechanism of action
None applicable (pseudogenes are not therapeutic targets)
03
Biological functions
None (pseudogenes are generally considered non-functional and do not perform known biological functions)
04
Disease associations
None (pseudogenes like RNU6-1127P do not have an established role in disease)
05
Safety considerations
None (no known therapeutic or diagnostic relevance)
06
Interacting drugs
None (there are no drugs targeting pseudogenes of U6 snRNA)
07
Biomarkers
None (not established as a biomarker for any condition)
Beyond the preview
Go deeper on RNA, U6 small nuclear 1127, pseudogene (RNU6-1127P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1127, pseudogene (RNU6-1127P).